Research Diagnosis Related Groups (DRG) level LOS quality outcomes for Eisenhower Medical Center located at 39000 Bob Hope Dr, Rancho Mirage, CA, 92270 & includes data from NPIs 1922183045, 1013981554
Dexur analyzed Q1 2018 (January to March 2018) Medicare claims data to benchmark length of stay (LOS) outcomes for Eisenhower Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jan 2018 to Mar 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 2,798 | 2,682 | ||||||||||
Surgical | 952 | 932 | ||||||||||
Non Surgical | 1,846 | 1,750 | ||||||||||
Orthopedics | 546 | 541 | ||||||||||
Cardiovascular | 536 | 509 | ||||||||||
General Medicine | 371 | 344 | ||||||||||
Pulmonology | 307 | 302 | ||||||||||
Gastroenterology & Endocrinology | 249 | 240 | ||||||||||
Neurology | 217 | 200 | ||||||||||
General Surgery | 183 | 169 | ||||||||||
Urology | 155 | 148 | ||||||||||
Oncology & Hematology | 92 | 87 | ||||||||||
Spine | 61 | 61 | ||||||||||
Colorectal | 36 | 36 | ||||||||||
Obstetrics & Gynecology | 18 | 18 | ||||||||||
Obesity, Bariatric, Stomach & Duodenal | 13 | 13 |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jan 2018 to Mar 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||
DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||
DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Medical Back Problems | ||||||||||||
DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Revision Of Hip Or Knee Replacement | ||||||||||||
DRG 468: REVISION OF HIP OR KNEE REPLACEMENT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Fractures Of Hip And Pelvis | ||||||||||||
DRG 536: FRACTURES OF HIP AND PELVIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Lower Extremity And Humerus Procedures Except Hip,Foot,Femur |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jan 2018 to Mar 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Heart Failure And Shock | ||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
Acute Myocardial Infarction | ||||||||||||
DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Permanent Cardiac Pacemaker Implant | ||||||||||||
DRG 243: PERMANENT CARDIAC PACEMAKER IMPLANT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Endovascular Procedures | ||||||||||||
DRG 266: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Circulatory System Diagnoses | ||||||||||||
Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
Syncope And Collapse | ||||||||||||
DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
Chest Pain | ||||||||||||
DRG 313: CHEST PAIN | ||||||||||||
Peripheral Vascular Disorders | ||||||||||||
Hypertension | ||||||||||||
Coronary Bypass |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jan 2018 to Mar 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Complications Of Treatment | ||||||||||||
DRG 920: COMPLICATIONS OF TREATMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Cellulitis | ||||||||||||
DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Signs And Symptoms | ||||||||||||
Poisoning And Toxic Effects Of Drugs |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jan 2018 to Mar 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Simple Pneumonia And Pleurisy | ||||||||||||
DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Chronic Obstructive Pulmonary Disease | ||||||||||||
DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Pulmonary Edema And Respiratory Failure | ||||||||||||
DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
Respiratory Infections And Inflammations | ||||||||||||
DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Respiratory System Diagnosis With Ventilator Support | ||||||||||||
DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
Bronchitis And Asthma | ||||||||||||
DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Pulmonary Embolism |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jan 2018 to Mar 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
G.I.Hemorrhage | ||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I. Obstruction | ||||||||||||
DRG 390: G.I. OBSTRUCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Diabetes | ||||||||||||
DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Cholecystectomy | ||||||||||||
Other Digestive System Diagnoses | ||||||||||||
DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Endocrine Disorders | ||||||||||||
Disorders Of Biliary Tract | ||||||||||||
Disorders Of Pancreas Except Malignancy |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jan 2018 to Mar 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 066: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Degenerative Nervous System Disorders | ||||||||||||
DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nonspecific Cerebrovascular Disorders | ||||||||||||
DRG 071: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Seizures | ||||||||||||
Traumatic Stupor And Coma, Coma < 1 Hour | ||||||||||||
Transient Ischemia | ||||||||||||
DRG 069: TRANSIENT ISCHEMIA |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jan 2018 to Mar 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Chest Procedures | ||||||||||||
Other Respiratory System O.R. Procedures |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jan 2018 to Mar 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Renal Failure | ||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Kidney And Urinary Tract Diagnoses | ||||||||||||
DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Kidney And Urinary Tract Infections | ||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Urinary Stones |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jan 2018 to Mar 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Respiratory Neoplasms | ||||||||||||
Red Blood Cell Disorders | ||||||||||||
Malignancy Of Hepatobiliary System Or Pancreas | ||||||||||||
Nervous System Neoplasms |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jan 2018 to Mar 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Spinal Fusion Except Cervical | ||||||||||||
DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Combined Anterior/Posterior Spinal Fusion |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jan 2018 to Mar 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures | ||||||||||||
DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |